Related Experiment Videos
Dipyridamole thallium imaging in patients being considered for vascular procedures
T F Kresowik1, T R Bower, S A Garner
1Department of Surgery, University of Iowa College of Medicine, Iowa City.
Insights
Dipyridamole thallium imaging is valuable for assessing coronary artery disease in patients undergoing vascular surgery. Its utility extends beyond patients with clinical symptoms, aiding therapeutic decisions.
Area of Science:
- Cardiology
- Nuclear Medicine
- Vascular Surgery
Background:
- Preoperative assessment of coronary artery disease (CAD) is crucial for patients undergoing major vascular procedures.
- Clinical indicators alone may not accurately predict the extent of CAD.
Purpose of the Study:
- To evaluate the diagnostic utility of intravenous dipyridamole thallium imaging in patients undergoing elective vascular procedures.
- To determine if clinical evidence of CAD influences the detection of significant coronary artery disease via dipyridamole thallium imaging.
Main Methods:
- Intravenous dipyridamole thallium imaging and resting radionuclide ventriculography were performed on 190 patients.
- Patients with thallium redistribution proceeded to coronary arteriography.
- Patients were stratified into two groups: with (Group 1) and without (Group 2) clinical evidence of CAD.
Main Results:
- Thallium redistribution occurred in 45% of Group 1 and 46% of Group 2 patients, showing no significant difference.
- Coronary arteriography revealed severe three-vessel or left main disease in 10% of Group 1 and 14% of Group 2 patients.
- The presence of clinical CAD indicators did not predict the likelihood of significant coronary findings.
Conclusions:
- Dipyridamole thallium imaging is effective in identifying significant CAD in vascular surgery patients, irrespective of clinical presentation.
- Patient selection for dipyridamole thallium imaging should prioritize its potential to influence therapeutic management rather than relying solely on clinical CAD suspicion.
Abstract:
We routinely performed intravenous dipyridamole thallium imaging and resting radionuclide ventriculography on 190 patients being considered for elective vascular procedures. Patients with thallium redistribution underwent coronary arteriography. Patients in group 1 (n = 78) had clinical evidence of coronary artery disease, and patients in group 2 (n = 112) had no history or electrocardiographic evidence of coronary artery disease. The frequency of thallium redistribution was not significantly different in the two groups (45% in group 1 and 46% in group 2). Coronary arteriography identified severe three-vessel or left main disease in eight patients (10%) in group 1 and 16 patients (14%) in group 2. Selection of patients for dipyridamole thallium imaging prior to vascular reconstruction should be based on whether or not documentation of the extent of coronary artery disease would influence therapy rather than on clinical indicators of coronary disease.